PPARG and urinary bladder carcinoma: In further support of a PPARγ-independent mechanism, the TZD ligands and 15dPGJ2 produced comparable growth inhibition in the TSU-Pr1/TSU-Pr1-B1/TSU-Pr1-B2 bladder carcinoma series despite increasing PPARγ expression.